Today, representatives from five pharmacy benefit managers — CVS, Optum, Cigna, Humana and Prime Therapeutics — are testifying before the Senate Finance Committee as part of a hearing to determine how to lower drug prices. Pharmacy benefit managers, or PBMs, “administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors.”
According to FierceHealthcare, drug rebates, and the proposal by the Department of Health and Human Services to eliminate such rebates, are likely to play a central role in today’s hearings.
Watch the testimony live:
Last week, prominent diabetes advocates from organizations including JDRF and the American Diabetes Association testified before Congress on the rising costs of insulin. Tomorrow, the three manufacturers of insulin in the United States — Eli Lilly, Novo Nordisk and Sanofi — along with CVS, Optum and Cigna will testify regarding insulin pricing practices.
Want to learn how to save money on your insulin? Read “Insulin Prices: Four Ways to Pay Less.”
Source URL: https://www.diabetesselfmanagement.com/blog/pharmacy-benefit-managers-to-testify-on-drug-prices/
Diane Fennell: Diane Fennell has been an editor at Diabetes Self-Management magazine since 2003. She is currently the Editorial Director. (Diane Fennell is not a medical professional.)
Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.
Copyright ©2020 Diabetes Self-Management unless otherwise noted.